Ignite Creation Date:
2024-05-06 @ 1:15 AM
Last Modification Date:
2024-10-26 @ 11:01 AM
Study NCT ID:
NCT01761461
Status:
UNKNOWN
Last Update Posted:
2020-03-25
First Post:
2013-01-03
Brief Title:
Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1Oxaliplatin Radiotherapy for Completely Resected Gastric Adenocarcinoma The ARTIST II Trial
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2020-03
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ARTIST-II
Brief Summary:
The optimal regimen for adjuvant treatment has not been established in GC yet We plan to compare TS-1 TS-1oxaliplatin with or without RT in D2 resected gastric cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None